CSPC Pharmaceutical Group Limited (CHJTF)

USD 0.64

(3.23%)

Inventory Summary of CSPC Pharmaceutical Group Limited

CSPC Pharmaceutical Group Limited's latest annual inventory in 2023 was 442.43 Million USD , up 20.49% from previous year.
CSPC Pharmaceutical Group Limited's latest quarterly inventory in 2024 Q1 was - USD , down -100.0% from previous quarter.
CSPC Pharmaceutical Group Limited reported annual inventory of 367.18 Million USD in 2022, down -5.62% from previous year.
CSPC Pharmaceutical Group Limited reported annual inventory of 389.06 Million USD in 2021, up 36.72% from previous year.
CSPC Pharmaceutical Group Limited reported quarterly inventory of - USD for 2024 Q1, down -100.0% from previous quarter.
CSPC Pharmaceutical Group Limited reported quarterly inventory of - USD for 2023 Q3, down -100.0% from previous quarter.

Annual Inventory Chart of CSPC Pharmaceutical Group Limited (2023 - 2015)

Historical Annual Inventory of CSPC Pharmaceutical Group Limited (2023 - 2015)

Year	Inventory	Inventory Growth
2023	442.43 Million USD	20.49%
2022	367.18 Million USD	-5.62%
2021	389.06 Million USD	36.72%
2020	284.57 Million USD	-21.83%
2019	364.03 Million USD	-17.64%
2018	442 Million USD	11.34%
2017	396.97 Million USD	47.71%
2016	268.75 Million USD	4.37%
2015	257.51 Million USD	0.0%

Year	Inventory	Inventory Growth
2024 Q2	475.93 Million USD	0.0%
2024 Q1	- USD	-100.0%
2023 Q3	- USD	-100.0%
2023 Q1	- USD	-100.0%
2023 Q2	378.73 Million USD	0.0%
2023 Q4	442.43 Million USD	0.0%
2023 FY	442.43 Million USD	20.49%
2022 Q4	367.18 Million USD	0.0%
2022 FY	367.18 Million USD	-5.62%
2022 Q2	391.9 Million USD	0.0%
2021 Q2	283.25 Million USD	0.0%
2021 FY	389.06 Million USD	36.72%
2021 Q4	389.06 Million USD	0.0%
2020 FY	284.57 Million USD	-21.83%
2020 Q4	284.57 Million USD	0.0%
2020 Q2	312.64 Million USD	0.0%
2019 FY	364.03 Million USD	-17.64%
2019 Q2	359.67 Million USD	0.0%
2019 Q4	364.03 Million USD	0.0%
2018 FY	442 Million USD	11.34%
2017 FY	396.97 Million USD	47.71%
2016 FY	268.75 Million USD	4.37%
2015 FY	257.51 Million USD	0.0%

Peer Inventory Comparison of CSPC Pharmaceutical Group Limited

Name	Inventory	Inventory Difference
AstraZeneca PLC	5.41 Billion USD	91.832%
Bristol-Myers Squibb Company PFD CONV 2	2.66 Billion USD	83.38%
Clarus Therapeutics Holdings, Inc.	14.21 Million USD	-3012.646%
Novartis AG	5.91 Billion USD	92.518%
PT Kalbe Farma Tbk.	451.27 Million USD	1.961%